← Back to Search

Behavioural Intervention

Remote Blood Pressure Monitoring + Telehealth for High Blood Pressure

N/A
Waitlist Available
Led By Lama Ghazi, MD, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age is equal to or greater than 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will test if checking blood pressure at home and working with pharmacists and doctors to manage it is doable. 24 participants will be enrolled, with 12 measuring blood pressure at home and

Who is the study for?
This trial is for individuals with high blood pressure. It's designed to see if monitoring their own blood pressure at home and having weekly phone consultations with pharmacists can help manage their condition better than the usual care.Check my eligibility
What is being tested?
The study is testing a new approach where half of the participants will monitor their blood pressure at home and have weekly telehealth sessions with pharmacists, while the other half receives standard medical care without these additions.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring and telehealth rather than medication or procedures, there are no direct side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total number of recruited participants

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Remote Blood Pressure Monitoring + TelehealthActive Control1 Intervention
Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
Group II: Usual CarePlacebo Group1 Intervention
Participants receive usual care from providers to manage their blood pressure

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,591 Previous Clinical Trials
2,281,641 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
384 Previous Clinical Trials
1,216,444 Total Patients Enrolled
Lama Ghazi, MD, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase for this investigation currently ongoing?

"As per the details provided on clinicaltrials.gov, it is evident that recruitment for this specific trial has ceased. The initial posting of this trial was made on June 1st, 2024, with the most recent update dated January 30th, 2024. However, despite the closure of this particular study to new participants, there are presently a total of 712 other trials actively seeking enrollees at present."

Answered by AI
~16 spots leftby Jun 2026